{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:45:30Z","timestamp":1761828330556,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jiac.2025.102836","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T06:32:04Z","timestamp":1761028324000},"page":"102836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Susceptibility of multidrug-resistant Aggregatibacter actinomycetemcomitans in vitro to amoxicillin-metronidazole and ciprofloxacin"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5735-717X","authenticated-orcid":false,"given":"Thomas E.","family":"Rams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arie J.","family":"van Winkelhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2025.102836_bib1","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/AAC.35.5.961","article-title":"Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans","volume":"35","author":"Pavici\u0107","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102836_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.archoralbio.2014.03.007","article-title":"Combinatorial effects of amoxicillin and metronidazole on selected periodontal bacteria and whole plaque samples","volume":"59","author":"Kulik","year":"2014","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.jiac.2025.102836_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/pathogens8040243","article-title":"Aggregatibacter Actinomycetemcomitans: clinical significance of a pathobiont subjected to ample changes in classification and nomenclature","volume":"8","author":"N\u00f8rskov-Lauritsen","year":"2019","journal-title":"Pathogens"},{"key":"10.1016\/j.jiac.2025.102836_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3390\/microorganisms8050661","article-title":"The microbiome of peri-implantitis: a systematic review and meta-analysis","volume":"8","author":"Sahrmann","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiac.2025.102836_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0757.1999.tb00160.x","article-title":"Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections","volume":"20","author":"van Winkelhoff","year":"2000","journal-title":"Periodontol"},{"key":"10.1016\/j.jiac.2025.102836_bib6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-051X.1989.tb01626.x","article-title":"Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis","volume":"16","author":"van Winkelhoff","year":"1989","journal-title":"J Clin Periodontol"},{"key":"10.1016\/j.jiac.2025.102836_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/clind\/16.2.216","article-title":"Long-standing bacteremia caused by oral Actinobacillus actinomycetemcomitans in a patient with a pacemaker","volume":"16","author":"van Winkelhoff","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2025.102836_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/clr.12160","article-title":"Antibiotic resistance in human peri-implantitis microbiota","volume":"25","author":"Rams","year":"2014","journal-title":"Clin Oral Implants Res"},{"key":"10.1016\/j.jiac.2025.102836_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/jcm.24.4.636-638.1986","article-title":"Comparison of two selective media for Actinobacillus actinomycetemcomitans","volume":"24","author":"Martijn van Steenbergen","year":"1986","journal-title":"J Clin Microbiol"},{"first-page":"112","year":"2024","series-title":"Performance standards for antimicrobial susceptibility testing","key":"10.1016\/j.jiac.2025.102836_bib10"},{"key":"10.1016\/j.jiac.2025.102836_bib11","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jac\/34.6.1047","article-title":"Amoxycillin causes an enhanced uptake of metronidazole in Actinobacillus actinomycetemcomitans: a mechanism of synergy","volume":"34","author":"Pavici\u0107","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2025.102836_bib12","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1128\/AAC.36.12.2634","article-title":"In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations","volume":"36","author":"Pavici\u0107","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2025.102836_bib13","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1902\/jop.1999.70.8.888","article-title":"Resistance profile survey of 50 periodontal strains of Actinobacillus actinomycetemcomitans","volume":"70","author":"Madinier","year":"1999","journal-title":"J Periodontol"},{"key":"10.1016\/j.jiac.2025.102836_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1040841X.2023.2197481","article-title":"Antibiotic resistance in the microbiota of periodontitis patients: an update of current findings","volume":"50","author":"Ng","year":"2024","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.jiac.2025.102836_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116162","article-title":"Systemic ciprofloxacin treatment of multidrug-resistant Aggregatibacter actinomycetemcomitans in severe periodontitis","volume":"108","author":"Rams","year":"2024","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X25002338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:35:46Z","timestamp":1761827746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X25002338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1341321X25002338"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102836","relation":{},"ISSN":["1341-321X"],"issn-type":[{"type":"print","value":"1341-321X"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility of multidrug-resistant Aggregatibacter actinomycetemcomitans in vitro to amoxicillin-metronidazole and ciprofloxacin","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2025.102836","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102836"}}